BioAge Labs Inc. (BIOA)
NASDAQ: BIOA
· Real-Time Price · USD
4.58
0.12 (2.69%)
At close: Aug 15, 2025, 3:47 PM
BioAge Labs Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | 2.41M | 1.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 2.35M | 1.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -24.77M | -16.45M | -25.36M | -24.75M | -15.27M | -12.81M | -13.6M | -9.89M | -13.41M | -11.51M |
Interest Income | 3.42M | n/a | 4.09M | 2.04M | 2.2M | 1.3M | 379K | 499K | 318K | 1.24M |
Pretax Income | -21.56M | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M | -14.63M | -17.19M | -11.08M |
Net Income | -21.56M | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M | -14.63M | -17.19M | -11.08M |
Selling & General & Admin | 7.28M | 6.79M | 6.14M | 4.73M | 4.8M | 3.49M | 3.51M | 3.35M | 4.18M | 3.47M |
Research & Development | 19.84M | 11.11M | 19.23M | 20.02M | 10.47M | 9.32M | 10.08M | 6.53M | 9.23M | 8.04M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 27.13M | 17.9M | 25.36M | 24.75M | 15.27M | 12.81M | 13.6M | 9.89M | 13.41M | 11.51M |
Interest Expense | 201K | -255K | 319K | 388K | 443K | 1.22M | 2.56M | 2.4M | 2.04M | 793K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.18M | 17.9M | 25.36M | 24.75M | 15.27M | 12.81M | 13.6M | 9.89M | 13.41M | 11.51M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 35.85M | 35.85M | 35.85M | 3.49M | 7.55M | 7.47M | 7.47M | 7.46M | 7.46M | 7.46M |
Shares Outstanding (Diluted) | 35.85M | 35.85M | 35.85M | 3.49M | 7.55M | 7.47M | 7.47M | 7.46M | 7.46M | 7.46M |
EPS (Basic) | -0.6 | -0.36 | -1.97 | -6.7 | -1.8 | -1.74 | -2.81 | -1.96 | -2.3 | -1.48 |
EPS (Diluted) | -0.6 | -0.36 | -1.97 | -6.7 | -1.8 | -1.74 | -2.81 | -1.96 | -2.3 | -1.48 |
EBITDA | -21.3M | -16.45M | -20.76M | -22.98M | -13.09M | -11.74M | -18.36M | -12.17M | -15.11M | -10.26M |
EBIT | -21.36M | -16.45M | -20.81M | -23.02M | -13.14M | -11.78M | -18.4M | -12.22M | -15.15M | -10.29M |
Depreciation & Amortization | 58K | 37K | 47K | 38K | 49K | 33K | 41K | 48K | 40K | 33K |